TREA

90603915 - KRAZATI

Follow

Information

  • Trademark
  • 90603915
  • Serial Number
    90603915
  • Registration Number
    7019779
  • Filing Date
    March 25, 2021
    3 years ago
  • Registration Date
    April 04, 2023
    a year ago
  • Transaction Date
    June 25, 2024
    6 months ago
  • Status Date
    April 04, 2023
    a year ago
  • Published for Opposition Date
    February 22, 2022
    2 years ago
  • Location Date
    February 27, 2023
    a year ago
  • First Use Anywhere Date
    December 13, 2022
    2 years ago
  • First Use In Commerce Date
    December 13, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HSU, FONG
  • Attorney Docket Number
    00163674-US
    Attorney Name
    Marilyn F. Kelly
    Law Office Assigned Location Code
    O20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
KRAZATI
Case File Statements
  • GS0051: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
  • GS0421: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Case File Event Statements
  • 3/29/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/30/2021 - 3 years ago
    2 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/30/2021 - 3 years ago
    3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/30/2021 - 3 years ago
    4 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/1/2021 - 3 years ago
    5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/1/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/8/2021 - 3 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/8/2021 - 3 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/8/2021 - 3 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/9/2021 - 3 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 12/20/2021 - 3 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/20/2021 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/20/2021 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/15/2022 - 2 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/15/2022 - 2 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/15/2022 - 2 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/15/2022 - 2 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/18/2022 - 2 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/2/2022 - 2 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/22/2022 - 2 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/22/2022 - 2 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/19/2022 - 2 years ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 10/17/2022 - 2 years ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/17/2022 - 2 years ago
    24 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/17/2022 - 2 years ago
    25 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/19/2022 - 2 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/2/2023 - a year ago
    27 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/2/2023 - a year ago
    29 - USE AMENDMENT FILED Type: IUAF
  • 1/30/2023 - a year ago
    28 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/1/2023 - a year ago
    30 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 2/27/2023 - a year ago
    31 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 2/28/2023 - a year ago
    32 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 6/25/2024 - 6 months ago
    35 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/25/2024 - 6 months ago
    36 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/25/2024 - 6 months ago
    37 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/4/2023 - a year ago
    34 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/4/2023 - a year ago
    33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR